MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues

International Journal of Oncology

Volumn 11, Issue 5, 1997, Pages 1045-1051

  Huang, Cheng Long ^a   Taki, Toshihiko ^a   Adachi, Masashi ^a   Yagita, Masato ^a   Sawada, Shinji ^a   Takabayashi, Arimichi ^a   Inufusa, Haruhiko ^b   Yoshie, Osamu ^c   Miyake, Masayuki ^a  

^a Kitano Hospital   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHIONOGI AND CO LTD   (Japan)

Author keywords

C33; KAI1 CD82; M31 15; MRP 1 CD9; Transmembrane 4 superfamily

Indexed keywords

CD82 ANTIGEN; CD9 ANTIGEN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LUNG CANCER; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030821772     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.5.1045     Document Type: Article

References (17)

1. Miyake M and Hakomori S: A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry 30: 3328-3334, 1991.
2. Miyake M, Koyama M, Seno M and Ikeyama S: Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 174: 1347-1354, 1991.
3. Boucheix C, Benoit P, Frachet P, Billard M, Worthington RE, Gagnon J and Uzan G: Molecular cloning of the CD9 antigen. J Biol Chem 266: 117-122, 1991.
4. Ikeyama S, Koyama M, Yamaoko M, Sasada R and Miyake M: Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177: 1231-1237, 1993.
5. Miyake M, Nakano K, Ieki Y, Adachi M, Huang C, Itoi S, Koh T and Taki T: Motility related protein-1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 55: 4127-4131, 1995.
6. Miyake M, Nakano K, Itoi S, Koh T and Taki T: Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 56: 1244-1249, 1996.
7. Higashiyama M, Taki T, Ieki Y, Adachi M, Huang C, Koh T, Kodama K, Doi O and Miyake M: Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res 55: 6040-6044, 1995.
8. Wright MD and Tomlinson MG: The ins and outs of the transmembrane 4 superfamily. Immunol Today 15: 588-594, 1994.
9. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11 p 11.2. Science 268: 884-886, 1995.
10. Gaugitsch HW, Hofer E, Huber NE, Schnabl E and Baumruker T: A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur J Immunol 21: 377-383, 1991.
11. Engel P, Wagner N and Tedder TF: CD82 workshop report. In: Leucocyte Typing. V. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF and Todd RF (eds). Oxford University Press, Oxford, pp691-693, 1995.
12. Adachi M, Taki T, Ieki Y, Huang C, Higashiyama M and Miyake M: Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 56: 1751-1755, 1996.
13. Classon BJ, Williams AF, Willis AC, Seed B and Stamenkovic I: The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J Exp Med 169: 1497-1502, 1989.
14. Amiot M: Identification and analysis of cDNA clones encoding CD53: a pan-leukocyte antigen related to membrane transport proteins. J Immunol 145: 4322-4325, 1990.
15. Hotta H, Ross AH, Huebner K, Isobe M, Wendebom S, Chao MV, Ricciardi RP, Tsujimoto Y, Croce CM and Koprowski H: Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 48: 2955-2962, 1988.
16. Oren R, Takahashi S, Doss C, Levy R and Levy S: TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol 10: 4007-4015, 1990.
17. Szala S, Kasai Y, Steplewski Z, Rodeck U, Koprowski H and Linnenbach AJ: Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci USA 87: 6833-6837, 1990.